This job is closed
Applications are no longer available for this announcement. Explore current related opportunities below.
Job description
Biopharmaceutical Corporate Business Development Lead
Immix Biopharna, Inc (NASDAQ:IMMX)
Our 3 Core Values
Integrity
Initiative
What You'll Do
Establish and maintain strong relationships with pharmaceutical and biotech companies; identify potential strategic corporate development and business partners
Source, screen and track business opportunities that are aligned with corporate goals and objectives by interacting with biotech, and pharma counterparts
Lead information research and provide robust analytic and business evaluation support of corporate and business development opportunities, potential company strategies, and key business initiatives
Develop and present robust financial models and market analyses to value projects
Visible external liaison in the scientific and biotech communities to raise awareness of company’s partnering objectives and capabilities
Attend strategic partnering and industry conferences related to therapeutic area of interest
Monitor and advise the Company’s leadership on competitive intelligence and relevant developments in key indications and therapeutic areas of interest
Skills and Experience We Look For
Bachelor’s degree or higher in biology, finance or related field with 5-10 years’ biopharma/pharmaceutical experience
Established track record of successful strategic transactions in the biopharmaceutical industry
Strong knowledge of biotechnology/pharmaceutical industry, drug discovery and development
Excellent verbal and written communication skills, strong relationship management skills and strategic thinking
Proven experience successfully supporting the scientific and business evaluation of technologies, assets, or companies in the biotechnology/pharmaceutical industry
Demonstrated understanding of pharmaceutical product lifecycle management including drug development, FDA regulations, and commercialization paths
Outstanding organizational, analytical, interpersonal and communication skills
Adaptability, flexibility, and willingness to work in a changing environment
Experience with financial analysis and/ or valuation of biopharmaceutical products and companies and advanced excel/modeling skills required
A collaborative nature with the knowledge and understanding of the role and importance of working cross-functionally
Self-starter, highly motivated, results-driven individual; ability to creatively solve problems
Process-minded with the ability to operate strategically and adapt when appropriate to execute on defined goals in a timely manner
Experience preparing and delivering presentations to senior management
Familiarity with biopharma / pharmaceutical portfolio strategy and competitive dynamics
About Immix Biopharma, Inc.
Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a global leader in AL Amyloidosis. AL Amyloidosis is a devastating disease where the immune system, that’s supposed to protect, instead produces toxic light chains, clogging up the heart, kidney and liver, causing organ failure and death. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a proprietary CD3ζ, CD8 hinge and binder “digital filter” designed to filter out non-specific activation. NXC-201 teaches the immune system to recognize and eliminate the source of the toxic light chains. NXC-201 is being evaluated in the U.S. multi-center study for relapsed/refractory AL Amyloidosis NEXICART-2 (NCT ), with a potentially registrational design. NXC-201 has been awarded Breakthrough Therapy Designation (BTD) and Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA.
#J-18808-Ljbffr
Worksite address
los angeles, CA, 90079, US
Who can apply
Review the original listing for work authorization, qualifications and employer requirements.